INDO US BIOTECH
Back to Balance Sheet
|
INDO US BIOTECH Last 5 Year Profit & Loss Account Balance History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit & Loss Account Balance | ₹36 Cr | ₹21 Cr | ₹22 Cr | ₹15 Cr | ₹11 Cr |
What is the latest Profit & Loss Account Balance ratio of INDO US BIOTECH ?
| Year | Profit & Loss Account Balance |
|---|---|
| Mar2025 | ₹36 Cr |
| Mar2024 | ₹21 Cr |
| Mar2023 | ₹22 Cr |
| Mar2022 | ₹15 Cr |
| Mar2021 | ₹11 Cr |
How is Profit & Loss Account Balance of INDO US BIOTECH Trending?
| Years | Profit & Loss Account Balance | % Change | |
|---|---|---|---|
| Mar2025 | ₹36 Cr | 76.54 | |
| Mar2024 | ₹21 Cr | -7.94 | |
| Mar2023 | ₹22 Cr | 47.92 | |
| Mar2022 | ₹15 Cr | 34.45 | |
| Mar2021 | ₹11 Cr | - | |
Compare Profit & Loss Account Balance of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹214.3 Cr | 2.3% | 6% | -33.4% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹10,134.7 Cr | 1.4% | -7% | -15.8% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,768.7 Cr | 6.9% | 14.9% | -36.5% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,083.2 Cr | 8.1% | 13.8% | -10.6% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,061.8 Cr | -9.8% | 20.4% | -20.4% | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹413.6 Cr | 12.8% | 22.9% | -13% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | 2.3% |
6% |
-33.4% |
| SENSEX | 3.7% |
-0.9% |
0.7% |
You may also like the below Video Courses